| A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes CJ Boushey, SAA Beresford, GS Omenn, AG Motulsky Jama 274 (13), 1049-1057, 1995 | 4869 | 1995 |
| Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease GS Omenn, GE Goodman, MD Thornquist, J Balmes, MR Cullen, A Glass, ... New England journal of medicine 334 (18), 1150-1155, 1996 | 3629 | 1996 |
| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression A Sreekumar, LM Poisson, TM Rajendiran, AP Khan, Q Cao, J Yu, ... Nature 457 (7231), 910-914, 2009 | 1510 | 2009 |
| ProteomeXchange provides globally coordinated proteomics data submission and dissemination JA Vizcaíno, EW Deutsch, R Wang, A Csordas, F Reisinger, D Rios, ... Nature biotechnology 32 (3), 223-226, 2014 | 1173 | 2014 |
| Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial GS Omenn, GE Goodman, MD Thornquist, J Balmes, MR Cullen, A Glass, ... JNCI: Journal of the National Cancer Institute 88 (21), 1550-1559, 1996 | 1170 | 1996 |
| Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database GS Omenn, DJ States, M Adamski, TW Blackwell, R Menon, H Hermjakob, ... Proteomics 5 (13), 3226-3245, 2005 | 763 | 2005 |
| A common open representation of mass spectrometry data and its application to proteomics research PGA Pedrioli, JK Eng, R Hubley, M Vogelzang, EW Deutsch, B Raught, ... Nature biotechnology 22 (11), 1459-1466, 2004 | 736 | 2004 |
| Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans Z Hrubec, GS Omenn Alcoholism: Clinical and Experimental Research 5 (2), 207-215, 1981 | 479 | 1981 |
| Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease B Hermanson, GS Omenn, RA Kronmal, BJ Gersh New England Journal of Medicine 319 (21), 1365-1369, 1988 | 410 | 1988 |
| An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: sensitivity and specificity analysis EA Kapp, F Schütz, LM Connolly, JA Chakel, JE Meza, CA Miller, D Fenyo, ... Proteomics 5 (13), 3475-3490, 2005 | 371 | 2005 |
| Total serum cholesterol levels and mortality risk as a function of age: a report based on the Framingham data RA Kronmal, KC Cain, Z Ye, GS Omenn Archives of internal medicine 153 (9), 1065-1073, 1993 | 371 | 1993 |
| The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol supplements GE Goodman, MD Thornquist, J Balmes, MR Cullen, FL Meyskens Jr, ... Journal of the National Cancer Institute 96 (23), 1743-1750, 2004 | 328 | 2004 |
| A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas T Farrah, EW Deutsch, GS Omenn, DS Campbell, Z Sun, JA Bletz, ... Molecular & cellular proteomics 10 (9), M110. 006353, 2011 | 309 | 2011 |
| Familial reticuloendotheliosis with eosinophilia GS Omenn New England Journal of Medicine 273 (8), 427-432, 1965 | 280 | 1965 |
| The β-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers GS Omenn, G Goodman, M Thornquist, J Grizzle, L Rosenstock, ... Cancer research 54 (7 Supplement), 2038s-2043s, 1994 | 277 | 1994 |
| Differential protein expression profiling by iTRAQ− 2DLC− MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype VG Keshamouni, G Michailidis, CS Grasso, S Anthwal, JR Strahler, ... Journal of proteome research 5 (5), 1143-1154, 2006 | 264 | 2006 |
| Meeting report: hazard assessment for nanoparticles—report from an interdisciplinary workshop JM Balbus, AD Maynard, VL Colvin, V Castranova, GP Daston, ... Environmental Health Perspectives 115 (11), 1654, 2007 | 250 | 2007 |
| Strategy and planning for chemopreventive drug development: clinical development plans II GJ Kelloff, JA Crowell, ET Hawk, VE Steele, RA Lubet, CW Boone, ... Journal of Cellular Biochemistry 63 (S26), 54-71, 1996 | 246 | 1996 |
| The human proteome project: current state and future direction P Legrain, R Aebersold, A Archakov, A Bairoch, K Bala, L Beretta, ... Molecular & cellular proteomics 10 (7), M111. 009993, 2011 | 239 | 2011 |
| Preventing coronary heart disease GS Omenn, SAA Beresford, AG Motulsky Circulation 97 (5), 421-424, 1998 | 236 | 1998 |